Literature DB >> 22259608

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation.

Won Ju Kee1, Myung Ho Jeong, Soo Young Jang, Min Goo Lee, Keun-Ho Park, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Jung Chaee Kang.   

Abstract

We report our experience of very late stent thrombosis (VLST) in a young male patient who underwent implantation of two paclitaxel-eluting stents (PES) six years ago. The patient was compliant with standard dual antiplatelet therapy, but he presented with acute myocardial infarction which was associated with VLST. Intravascular ultrasound showed neointimal rupture with thrombus within the PES implanted in the right coronary artery. The lesion was successfully treated with balloon angioplasty without complications, however he was found to be hyporesponsive to clopidogrel when tested for adenosine diphosphate-induced platelet aggregation. The patient was discharged after uneventful recovery with triple anti-platelet therapy using aspirin, clopidogrel and cilostazol. To the best of our knowledge, a time interval of 2,223 days is the longest reported time interval between PES deployment and VLST occurrence. VLST may indeed occur in clinically stable patients, as multiple factors can influence the pathological mechanisms of VLST.

Entities:  

Keywords:  Clopidogrel; Coronary thrombosis; Paclitaxel; Ultrasonics

Year:  2011        PMID: 22259608      PMCID: PMC3257461          DOI: 10.4070/kcj.2011.41.12.754

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  14 in total

1.  Stent thrombosis in randomized clinical trials of drug-eluting stents.

Authors:  Laura Mauri; Wen-hua Hsieh; Joseph M Massaro; Kalon K L Ho; Ralph D'Agostino; Donald E Cutlip
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

2.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

3.  Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.

Authors:  Peter Wenaweser; Joost Daemen; Marcel Zwahlen; Ron van Domburg; Peter Jüni; Sophia Vaina; Gerrit Hellige; Keiichi Tsuchida; Cyrill Morger; Eric Boersma; Neville Kukreja; Bernhard Meier; Patrick W Serruys; Stephan Windecker
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

4.  Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair.

Authors:  C Rogers; S Parikh; P Seifert; E R Edelman
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

5.  Pathological analysis of local delivery of paclitaxel via a polymer-coated stent.

Authors:  A Farb; P F Heller; S Shroff; L Cheng; F D Kolodgie; A J Carter; D S Scott; J Froehlich; R Virmani
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

6.  Difference in neointimal proliferation between ruptured and non-ruptured segments after bare metal stent implantation.

Authors:  Shinya Yokoyama; Masamichi Takano; Shunta Sakai; Takayoshi Ohba; Koji Seimiya; Kentaro Okamatsu; Shigenobu Inami; Noritake Hata; Kyoichi Mizuno
Journal:  Int Heart J       Date:  2010-01       Impact factor: 1.862

7.  Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Carlos Barrera-Ramirez; Manel Sabaté; Rosana Hernández; Raul Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Journal:  Thromb Res       Date:  2005       Impact factor: 3.944

8.  Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement.

Authors:  Iris Müller; Felicitas Besta; Christian Schulz; Steffen Massberg; Albert Schönig; Meinrad Gawaz
Journal:  Thromb Haemost       Date:  2003-05       Impact factor: 5.249

9.  Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.

Authors:  Stephen G Ellis; Antonio Colombo; Eberhard Grube; Jeffrey Popma; Joerg Koglin; Keith D Dawkins; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

10.  Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm.

Authors:  Sang-Hoon Seol; Doo-Il Kim; Yang-Chun Han; Ki-Hun Kim; Dong-Kie Kim; Young-Bok Kim; Ung Kim; Tae-Hyun Yang; Dae-Kyeong Kim; Dong-Soo Kim
Journal:  Korean Circ J       Date:  2009-10-28       Impact factor: 3.243

View more
  1 in total

1.  The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model.

Authors:  In-Ho Bae; Myung Ho Jeong; Ju Han Kim; Yong Hwan Park; Kyung Seob Lim; Dae Sung Park; Jae Won Shim; Jung Ha Kim; Youngkeun Ahn; Young Joon Hong; Doo Sun Sim
Journal:  Korean Circ J       Date:  2016-12-23       Impact factor: 3.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.